Quinn Sean Edward 4
4 · CIMPRESS plc · Filed May 29, 2026
Research Summary
AI-generated summary of this filing
Cimpress (CMPR) CFO Sean Quinn Sells Shares, Exercises Options
What Happened
Sean Quinn, Chief Financial Officer of Cimpress plc (CMPR), exercised 5,009 stock options (exercise cost $46.20/share, ~$231,416) and sold a total of approximately 27,989 Cimpress shares in open-market transactions on May 27–28, 2026. The reported sale proceeds total about $2,925,909 (sales ranged across transactions with weighted-average prices shown below). The exercised shares were sold the same day, effectively a cashless exercise and sale.
Key Details
- Transaction dates: May 27–28, 2026; Form 4 filed May 29, 2026 (timely filing).
- Sales (open market): 300 shares @ $103.55 = $31,065 (F1); 20,534 @ $104.57 = $2,147,240 (F2); 2,146 @ $105.11 = $225,566 (F3); 5,009 @ $104.22 = $522,038 (F4). Total proceeds ≈ $2,925,909.
- Option exercise (M): 5,009 shares exercised @ $46.20 = $231,416 (acquired), then those 5,009 shares were sold the same day. A separate derivative disposition of 5,009 units is reported at $0 (standard reporting of option conversion).
- Footnotes: F1–F4 note weighted-average sale prices with per-share price ranges (details available on request). F5 describes the original option vesting schedule (25% on first vest date, then 6.25% quarterly).
- Shares owned after transaction: not specified in the provided summary—see the filed Form 4 for ending holdings.
- Transaction codes: S = sale, M = option exercise/derivative conversion. Filing status: timely (no late filing flag).
Context
Because the options were exercised and the resulting shares sold the same day, this is effectively a cashless exercise followed by a sale rather than a long-term buy signal. Sales by executives can be routine (tax or diversification) and do not, by themselves, indicate company outlook. For full details (exact per-share prices within the reported ranges and ending holdings), consult the official Form 4 filing (Accession 0001621706-26-000006).
Insider Transaction Report
- Sale
Ordinary Shares
[F1]2026-05-27$103.55/sh−300$31,065→ 51,617 total - Sale
Ordinary Shares
[F2]2026-05-27$104.57/sh−20,534$2,147,240→ 31,083 total - Sale
Ordinary Shares
[F3]2026-05-27$105.11/sh−2,146$225,566→ 28,937 total - Exercise/Conversion
Ordinary Shares
2026-05-28$46.20/sh+5,009$231,416→ 33,946 total - Sale
Ordinary Shares
[F4]2026-05-28$104.22/sh−5,009$522,038→ 28,937 total - Exercise/Conversion
Option (right to buy)
[F5]2026-05-28−5,009→ 69,189 totalExercise: $46.20From: 2023-06-30Exp: 2032-08-15→ Ordinary Shares (5,009 underlying)
Footnotes (5)
- [F1]Reflects weighted-average sale price (per share prices actually received ranged from $103.51 to $103.63). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
- [F2]Reflects weighted-average sale price (per share prices actually received ranged from $104.02 to $104.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range
- [F3]Reflects weighted-average sale price (per share prices actually received ranged from $105.00 to $105.48). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range
- [F4]Reflects weighted-average sale price (per share prices actually received ranged from $103.51 to $104.50). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.
- [F5]This option becomes exercisable as to 25% of the original number of shares on the Date Exercisable on Table II, and as to an additional 6.25% of the original number of shares on the last day of each successive fiscal quarter thereafter.